Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cells.

MLA

Kiefer, Maximilian, et al. “Ars2-Containing Bispecific, Fab- and IgG1-Format BAR-Bodies to Target DLBCL Cells.” EJHaem, vol. 4, no. 1, Dec. 2022, pp. 125–34. EBSCOhost, https://doi.org/10.1002/jha2.635.

APA

Kiefer, M., Thurner, L., Bock, T., Cetin, O., Kos, I., Lesan, V., Kaddu-Mulindwa, D., Bittenbring, J. T., Fadle, N., Regitz, E., Hoth, M., Neumann, F., Preuss, K.-D., Pfreundschuh, M., Christofyllakis, K., & Bewarder, M. (2022). Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cells. EJHaem, 4(1), 125–134. https://doi.org/10.1002/jha2.635

Chicago

Kiefer, Maximilian, Lorenz Thurner, Theresa Bock, Onur Cetin, Igor Kos, Vadim Lesan, Dominic Kaddu-Mulindwa, et al. 2022. “Ars2-Containing Bispecific, Fab- and IgG1-Format BAR-Bodies to Target DLBCL Cells.” EJHaem 4 (1): 125–34. doi:10.1002/jha2.635.